| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |